These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1533598)
21. [Experience with the use of pancuronium bromide in cesarean section]. Kralert M Cesk Gynekol; 1972 Mar; 37(2):80-1. PubMed ID: 4260114 [No Abstract] [Full Text] [Related]
23. [The neuromuscular junction and mechanism of action of curariform drugs]. Kienlen J Ann Fr Anesth Reanim; 1984; 3(2):116-28. PubMed ID: 6231869 [No Abstract] [Full Text] [Related]
24. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission. Lu TC J Pharmacol Exp Ther; 1970 Sep; 174(3):560-6. PubMed ID: 4247938 [No Abstract] [Full Text] [Related]
25. Proceedings: Quantifying myoneural block induced relaxation. Ragsdale DW; Anderson AD; Long FM Biomed Sci Instrum; 1974 Apr; 10():1-5. PubMed ID: 4274721 [No Abstract] [Full Text] [Related]
26. [1st clinical experiences with a new relaxant, pancuronium bromide]. Brunner H Wien Med Wochenschr; 1970 Oct; 120(44):766-7. PubMed ID: 4248744 [No Abstract] [Full Text] [Related]
28. [Mechanism of action of muscle relaxants and its clinical problems]. Suzuki H Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420 [No Abstract] [Full Text] [Related]
29. Skeletal muscle relaxants: pharmacodynamics and pharmacokinetics in different patient groups. Booij LH; Vree TB Int J Clin Pract; 2000 Oct; 54(8):526-34. PubMed ID: 11198732 [TBL] [Abstract][Full Text] [Related]
30. [Study of possible changes in curarization according to sex in adult Wistar rats]. Bouyard P; Gastaut JA; Giudicelli H; Jadot G C R Seances Soc Biol Fil; 1972 Nov; 166(2):418-22. PubMed ID: 4267754 [No Abstract] [Full Text] [Related]
31. [Comparative study based upon the provoked potentials of various curare-like agents used in clinical practice]. Schlagdenhauffen J Anesth Analg (Paris); 1973; 30(5):929-34. PubMed ID: 4276288 [No Abstract] [Full Text] [Related]
32. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium]. Danilov AF Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151 [No Abstract] [Full Text] [Related]
34. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents. Scaf AH; van den Akker J; Berends F Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930 [No Abstract] [Full Text] [Related]
35. [Specificity of pharmacological trials and the idea of target structures]. Valette G Biol Med (1971); 1974 Jun; 3(1):1-19. PubMed ID: 4157176 [No Abstract] [Full Text] [Related]
36. The use of neuromuscular blocking agents to investigate receptor structure requirements for histamine release. Buckett WR; Frisk-Holmberg M Br J Pharmacol; 1970 Sep; 40(1):165P-166P. PubMed ID: 4098852 [No Abstract] [Full Text] [Related]
37. Effects of succinylcholine on the recovery of block produced by mivacurium in rats. Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002 [TBL] [Abstract][Full Text] [Related]
38. [Neuromuscular depression induced by magnesium chloride and magnesium sulfate]. Plume C Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):411-4. PubMed ID: 4259408 [No Abstract] [Full Text] [Related]
39. Histamine release from rat peritoneal mast cells and cat paws induced by some neuromuscular blocking agents. Frisk-Holmberg M; Strandberg K Acta Physiol Scand; 1971 Mar; 81(3):367-75. PubMed ID: 4101373 [No Abstract] [Full Text] [Related]